Detalhe da pesquisa
1.
Oncologic emergencies and urgencies: A comprehensive review.
CA Cancer J Clin
; 72(6): 570-593, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35653456
2.
Incidence, Correlates, and Prognostic Significance of Mixed Response in Advanced Non-small Cell Lung Cancer.
Oncologist
; 29(4): 342-349, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38207008
3.
Emerging Strategies in Lung Cancer Screening: Blood and Beyond.
Clin Chem
; 70(1): 60-67, 2024 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38175587
4.
Effect of Patient Navigation on Completion of Lung Cancer Screening in Vulnerable Populations.
J Natl Compr Canc Netw
; 22(3): 151-157, 2024 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38489927
5.
Geographic Accessibility and Completion of Initial Low-Dose CT-Based Lung Cancer Screening in an Urban Safety-Net Population.
J Natl Compr Canc Netw
; : 1-7, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38670152
6.
Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study.
Lancet Oncol
; 24(9): 1002-1017, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37657460
7.
Quantitation of cardiac troponin I in cancer patients treated with immune checkpoint inhibitors: a case-control study.
Clin Chem Lab Med
; 61(1): 154-161, 2023 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36287134
8.
AXL Inhibitors: Status of Clinical Development.
Curr Oncol Rep
; 25(5): 521-529, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920638
9.
Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors.
Cancer Immunol Immunother
; 71(9): 2169-2181, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35072744
10.
Potential Impact of Revised NCI Eligibility Criteria Guidance: Prior Malignancy Exclusion in Breast Cancer Clinical Trials.
J Natl Compr Canc Netw
; 20(7): 792-799.e4, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35830895
11.
Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review.
Semin Cancer Biol
; 64: 93-101, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31330185
12.
Survival of women diagnosed with breast cancer and who have survived a previous cancer.
Breast Cancer Res Treat
; 187(3): 853-865, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33620590
13.
Reimbursement Matters: Overcoming Barriers to Clinical Trial Accrual.
Med Care
; 59(5): 461-466, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33492049
14.
Experience, Perceptions, and Recommendations Concerning COVID-19-Related Clinical Research Adjustments.
J Natl Compr Canc Netw
; 19(5): 505-512, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33027755
15.
Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology.
Cancer
; 126(8): 1605-1613, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31967687
16.
Lack of Association Between Radiographic Tumor Burden and Efficacy of Immune Checkpoint Inhibitors in Advanced Lung Cancer.
Oncologist
; 25(6): 515-522, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32233048
17.
Statin Intolerance, Anti-HMGCR Antibodies, and Immune Checkpoint Inhibitor-Associated Myositis: A "Two-Hit" Autoimmune Toxicity or Clinical Predisposition?
Oncologist
; 25(8): e1242-e1245, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32400023
18.
Late-Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor-Induced Raynaud's-Like Phenomenon.
Oncologist
; 25(5): e753-e757, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32167195
19.
Investigational Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Event Prediction and Diagnosis.
Clin Chem
; 66(6): 779-793, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32363387
20.
Unique Patterns of Distant Metastases in HPV-Positive Head and Neck Cancer.
Oncology
; 98(3): 179-185, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31846962